Offer intensifies a longstanding battle between OpenAI CEO Sam Altman and Elon Musk over the future of the AI leader. Read ...

The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

A dollar in corporate profit isn't always what it's cracked up to be. The post The US stock market has an earnings quality ...

The billionaire's attorney, Marc Toberoff, confirmed he submitted the bid for "all assets" of the company on Monday.